Performance of FRE Fresenius SE & Co. KGaA | 11.4% in 12m
Compare FRE with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Fresenius SE & Co. KGaA with its related Sector/Index XLV
Performance Duell FRE vs XLV
| TimeFrame | FRE | XLV |
|---|---|---|
| 1 Week | -0.45% | -2.07% |
| 1 Month | 8.38% | 4.37% |
| 3 Months | 9.42% | 5.66% |
| 6 Months | 32.7% | 6.23% |
| 12 Months | 11.4% | 17.65% |
| YTD | 14.5% | 11.77% |
| Rel. Perf. 1m | 0.23 | |
| Rel. Perf. 3m | 0.99 | |
| Rel. Perf. 6m | 2.09 | |
| Rel. Perf. 12m | 2.09 | |
| Spearman 1m | 0.95 | 0.82 |
| Spearman 3m | 0.90 | 0.89 |
Is Fresenius SE & Co. KGaA a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Fresenius SE & Co. KGaA is currently (September 2024)
neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -3.37 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FRE as of September 2024 is 35.83. This means that FRE is currently overvalued and has a potential downside of 7.86% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FRE as of September 2024 is 35.83. This means that FRE is currently overvalued and has a potential downside of 7.86% (Sold with Premium).
Is FRE a buy, sell or hold?
Fresenius SE & Co. KGaA has no consensus analysts rating. ValueRay therefore judges the recommendation based on the last 12 Month Returns of 11.36%.
In compare to Health Care Sector SPDR Fund, FRE made -6.29% less over the last 12 months. Due to the underperformance, it is recommend to sell FRE.
In compare to Health Care Sector SPDR Fund, FRE made -6.29% less over the last 12 months. Due to the underperformance, it is recommend to sell FRE.
Values above 0%: FRE is performing better - Values below 0%: FRE is underperforming
Compare FRE with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.69% | 4.89% | 26.04% | -10.82% |
| US NASDAQ 100 | QQQ | 5.34% | 6.30% | 30.17% | -8.49% |
| US Dow Jones Industrial 30 | DIA | 2.37% | 4.58% | 27.42% | -7.14% |
| German DAX 40 | DBXD | 2.79% | 2.98% | 29.89% | -3.24% |
| UK FTSE 100 | ISFU | 1.80% | 2.11% | 20.40% | -6.80% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.23% | 10.69% | 38.99% | 22.27% |
| Hongkong Hang Seng | HSI | 1.77% | 3.61% | 32.21% | 17.20% |
| Japan Nikkei 225 | EXX7 | 6.67% | 2.70% | 42.85% | 5.50% |
| India NIFTY 50 | INDA | 1.65% | 5.77% | 24.28% | -12.95% |
| Brasil Bovespa | EWZ | 1.26% | 1.50% | 41.23% | 11.12% |
FRE Fresenius SE & Co. KGaA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.62% | 7.79% | 25.35% | -13.16% |
| Consumer Discretionary | XLY | 2.07% | 2.99% | 30.73% | 5.27% |
| Consumer Staples | XLP | -1.03% | 2.31% | 20.90% | -6.79% |
| Energy | XLE | 5.32% | 9.50% | 32.40% | 13.50% |
| Financial | XLF | 2.72% | 1.66% | 22.82% | -19.38% |
| Health Care | XLV | 1.62% | 4.01% | 26.49% | -6.29% |
| Industrial | XLI | 3.79% | 5.23% | 28.51% | -9.71% |
| Materials | XLB | 4.21% | 6.79% | 30.62% | -0.29% |
| Real Estate | XLRE | -0.63% | 3.37% | 20.95% | -12.01% |
| Technology | XLK | 7.00% | 6.72% | 33.97% | -6.96% |
| Utilities | XLU | 0.05% | 4.21% | 10.60% | -12.40% |
| Aerospace & Defense | XAR | 4.76% | 4.38% | 28.25% | -14.98% |
| Biotech | XBI | 4.23% | 6.18% | 36.20% | -11.25% |
| Homebuilder | XHB | 3.95% | 4.96% | 24.88% | -26.24% |
| Retail | XRT | 4.53% | 8.89% | 35.97% | -7.29% |
Does Fresenius SE & Co. KGaA outperform its market, is FRE a Sector Leader?
No, over the last 12 months Fresenius SE & Co. KGaA (FRE) made 11.36%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 17.65%.
Over the last 3 months FRE made 9.42%, while XLV made 5.66%.
No, over the last 12 months Fresenius SE & Co. KGaA (FRE) made 11.36%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 17.65%.
Over the last 3 months FRE made 9.42%, while XLV made 5.66%.
| Period | FRE | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 8.38% | 4.37% | 3.49% |
| 3 Months | 9.42% | 5.66% | 1.39% |
| 12 Months | 11.36% | 17.65% | 22.18% |